Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lampert

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Adolescent and Young Adult Oncology|April 29, 2024
The Not-So-Good Cancer: Psychosocial Challenges for YA Thyroid Cancer Patients and Survivors and the Creation of a YA Thyroid Cancer Support GroupSara L Lampert-Okin
Pharmacy World & Science : PWS|March 22, 2008
Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University HospitalMarkus L Lampert, Stephan Kraehenbuehl, Balthasar L Hug
Journal of Alternative and Complementary Medicine (New York, N.Y.)|September 7, 2018
Barriers to Achieving Optimal Success with Medical Cannabis: Opportunities for Quality ImprovementLeslie Mendoza Temple, Sara L Lampert, Bernard Ewigman
International Journal of Clinical Pharmacy|February 7, 2018
Pharmaceutical interventions on prescribed medicines in community pharmacies: focus on patient-reported problemsKaren A Maes, Kurt E Hersberger, Markus L Lampert
Pharmacy (Basel, Switzerland)|February 10, 2021
Pharmaceutical Discharge Management: Implementation in Swiss Hospitals Compared to International GuidelinesHelene Studer, Fabienne Boeni, Kurt E Hersberger, et al.
International Journal of Clinical Pharmacy|March 3, 2017
Documentation of pharmaceutical care: development of an intervention oriented classification systemKaren A Maes, Sophia Bruch, Kurt E Hersberger, et al.
Praxis|December 8, 2007
[Unexpected loss of therapeutic effect of oxcarbazepine]M L Lampert, A E Rätz Bravo, S Brugger, et al.
BMJ Open|March 22, 2015
Determination of risk factors for drug-related problems: a multidisciplinary triangulation processCarole P Kaufmann, Dominik Stämpfli, Kurt E Hersberger, et al.
Genes|July 27, 2024
Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical PracticeFlorine M Wiss, Deborah Jakober, Markus L Lampert, et al.
International Journal of Clinical Pharmacy|August 4, 2011
Drug-related problems in diabetes and transplant patients: an observational study with home visitsPatrick M Eichenberger, Manuel Haschke, Markus L Lampert, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Adolescent and Young Adult Oncology|April 29, 2024
The Not-So-Good Cancer: Psychosocial Challenges for YA Thyroid Cancer Patients and Survivors and the Creation of a YA Thyroid Cancer Support GroupSara L Lampert-Okin
Pharmacy World & Science : PWS|March 22, 2008
Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University HospitalMarkus L Lampert, Stephan Kraehenbuehl, Balthasar L Hug
Journal of Alternative and Complementary Medicine (New York, N.Y.)|September 7, 2018
Barriers to Achieving Optimal Success with Medical Cannabis: Opportunities for Quality ImprovementLeslie Mendoza Temple, Sara L Lampert, Bernard Ewigman
International Journal of Clinical Pharmacy|February 7, 2018
Pharmaceutical interventions on prescribed medicines in community pharmacies: focus on patient-reported problemsKaren A Maes, Kurt E Hersberger, Markus L Lampert
Pharmacy (Basel, Switzerland)|February 10, 2021
Pharmaceutical Discharge Management: Implementation in Swiss Hospitals Compared to International GuidelinesHelene Studer, Fabienne Boeni, Kurt E Hersberger, et al.
International Journal of Clinical Pharmacy|March 3, 2017
Documentation of pharmaceutical care: development of an intervention oriented classification systemKaren A Maes, Sophia Bruch, Kurt E Hersberger, et al.
Praxis|December 8, 2007
[Unexpected loss of therapeutic effect of oxcarbazepine]M L Lampert, A E Rätz Bravo, S Brugger, et al.
BMJ Open|March 22, 2015
Determination of risk factors for drug-related problems: a multidisciplinary triangulation processCarole P Kaufmann, Dominik Stämpfli, Kurt E Hersberger, et al.
Genes|July 27, 2024
Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical PracticeFlorine M Wiss, Deborah Jakober, Markus L Lampert, et al.
International Journal of Clinical Pharmacy|August 4, 2011
Drug-related problems in diabetes and transplant patients: an observational study with home visitsPatrick M Eichenberger, Manuel Haschke, Markus L Lampert, et al.
Pageof 5